Spironolactone Tablet, Film Coated
Product Images NDC 43063-974

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 43063-974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063974 Label (43063974)

43063974 Label (43063974)
This is a label for a bottle containing Spironolactone, which is a medication used to treat high blood pressure or excess fluid retention caused by certain conditions like heart failure or kidney disease. It's made by 2 Pharmaceuticals Inc. and the bottle contains 90 tablets of 50mg each. The reorder number is 110793 and it expires in November 2021. The label advises patients to take the tablets 2 to 3 times daily and to call a doctor if they experience side effects which can also be reported to the FDA.*
FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)

Figure 1.  Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 1)
The text is not available for generating a useful description.*
FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)

Figure 2.  Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Spironolactone Figure 2)
This appears to be a chart or table with headings "Subgroup" and "-vy — 5" and a series of numbers listed underneath. There is also a line with the numbers 02, 04, 06, 08, 1.0, 1.2, and 1.4. The text "Spironolactone better" and "Placebo better" are listed underneath this line, possibly indicating the results of a study or experiment. Without further context, it is difficult to provide a specific description of the contents of this chart or table.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.